Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes — ScienceDai…

Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSCs), were…

Click here to view the original article.